Pixium CEO Sees Great Promise for PRIMA Implant

Medtech Talk

English - February 06, 2018 05:00 - 33 minutes - 15.2 MB - ★★★★★ - 56 ratings
Investing Business Health & Fitness medtech medical device venture capital health care innovation cardiology start-ups orthopedics digital health fda Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: SVB’s Numbers Guru Jon Norris Points to More Investors, Stronger Exits Facing Medtech in 2018

Next Episode: LRVHealth Tapping Providers for New $100 Million Fund

Khalid Ishaque says Bioelectronic Medicine has made great strides in treating hearing loss, depression, and other maladies and shows great promise in treating neurological disorders like Alzheimer's disease. Yet, most people still see it as more science fiction than science fact. But that's changing. "What we are demonstrating with advances in miniaturization, imaging, and increased understanding of the cellular pathways and the brain is that what was once considered impossible is becoming possible," he declares.

Overview: Pixium Vision is making great progress with its PRIMA subretinal implant.

Surprises: I thought the study was limited to Europe, but the company will be enrolling patients in Pittsburgh too.

Regrets: I should have asked a bit more about the technology's origins.